Conference News
-
19 May 2012Comments ( 0 )
Preliminary results from a placebo-controlled trial of the antibiotic minocycline in children with fragile X syndrome suggest the drug alleviates some aspects of the disorder, according to research presented Friday at the International Meeting for Autism Research in Toronto.
-
18 May 2012Comments ( 0 )
Neuroscience funding has plateaued, so researchers need to squeeze every drop from existing data.
-
18 May 2012Comments ( 0 )
By studying pregnant women who already have a child with autism, researchers hope to understand how epigenetic changes — those that affect gene expression but don’t directly alter DNA — during pregnancy influences risk of the disorder.
-
17 May 2012Comments ( 0 )
Two new studies on oxytocin, the so-called ‘trust hormone,’ suggest new avenues for using the drug to treat autism.
-
14 May 2012Comments ( 0 )
The past few years have seen an unprecedented number of clinical trials for experimental drugs to treat autism-related disorders, most notably for fragile X syndrome. But as the trials progress, scientists are calling for better methods to measure the drugs’ effectiveness.



